News

Diseases such as systematic lupus erythematosus (SLE) and rheumatoid arthritis (RA) may present early (patients aged in their 30s and 40s) or have a late onset (age of 55 years and older).
Systemic lupus erythematosus, a.k.a. lupus, is a chronic autoimmune condition that causes the immune system to attack healthy tissues and organs. It can affect the joints, skin, kidneys, blood ...
Medical invalidation creates a dangerous cycle where patients develop “healthcare trauma,” avoid seeking further medical care, and face diagnostic delays averaging 6.7 years. This “silent epidemic” ...
About Enpatoran Enpatoran is a selective Toll-like receptor (TLR)7/8 inhibitor under investigation for the treatment of systemic lupus erythematosus (SLE) and cutaneous lupus erythematosus (CLE).
ABSTRACT: Background: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease where the immune system mistakenly attacks the body’s own tissues and organs. It leads to a range of symptoms, ...
ORLANDO — Twice-daily deucravacitinib 3 mg and 6 mg significantly improved cutaneous lupus erythematosus activity by week 16, according to a presenter at the American Academy of Dermatology ...
Patients whose autoimmune disorders such as lupus were initially dismissed by doctors as psychosomatic show long-lasting adverse impacts on their mental health and trust in medicine, according to ...
Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of the CorEvitas Systemic Lupus Erythematosus Registry.
Lupus affects different people in different ways, and skin problems like rashes or sores re common. In a new study, people with systemic lupus erythematosus (SLE) were found to be at higher risk for ...
Lupus or Systematic Lupus Erythematosus is a condition where the body’s immune system attacks the body’s own tissues and organs, causing inflammation. Lupus may develop as a result of a genetic ...
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease. In this Care Cues, experts discuss strategies to promote shared decision-making with their SLE patients.